We compared the effectiveness between starting with oral versus subcutaneous MTX over the first year. Longitudinal multivariable models, adjusted for potential baseline and time-varying confounders, ...

By minimizing time spent in medical facilities, the subcutaneous version could improve treatment adherence and patients' quality of life. Dr. Eric K. Singhi shares his insights into the advantages of ...

Immunotherapy, exemplified by Opdivo, enhances cancer treatment by targeting malignant cells using the immune system, offering a more precise approach than traditional therapies. The FDA approved ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

Bowel cancer can start in the large bowel (colon cancer) or back passage (rectal cancer). It is also called colorectal cancer.. Your treatment depends on whether you have colon or rectal cancer. Your ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...

Stew Pidd, CEO Subscribers to The Economist can sign up to our new Opinion newsletter, which brings together the best of our leaders, columns, guest essays and reader correspondence.

Other common causes include Haemophilus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae. Antibiotic drugs, which treat bacterial infections, are the primary form of treatment for bacterial ...

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU that can be delivered via an autoinjector device at home.

For both reasons, each person’s treatment plan will be different. Read on to learn about the types of MS treatments available. Disease-modifying therapies (DMTs) can reduce the frequency and ...

Towards the end of life, you might want to make decisions about your care. This includes any instructions for refusing treatment. It can sometimes be very difficult to know what care and treatment to ...

Hympavzi is the first once-weekly subcutaneous treatment for people living with haemophilia B administered using a pen-injector and the first treatment administered as a flat dose – i.e., not ...